Regulation of the transcription factor AP-1 in benign and malignant mouse keratinocyte cells

Molecular Carcinogenesis

Volumn 18, Issue 1, 1997, Pages 26-36

  Joseloff, Elizabeth ^a   Bowden, G Tim ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

jun B; phosphorylation; ref 1; skin cancer

Indexed keywords

ONCOPROTEIN; PHORBOL ESTER; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; KERATINOCYTE; MOUSE; NONHUMAN; ONCOGENE C FOS; ONCOGENE C JUN; PHOSPHORYLATION; PRIORITY JOURNAL; REGULATORY MECHANISM; TUMOR CELL;

ANIMALS; ANTIBODIES; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL TRANSFORMATION, NEOPLASTIC; DNA; ELECTROPHORESIS, POLYACRYLAMIDE GEL; KERATINOCYTES; METHIONINE; MICE; MICE, INBRED BALB C; OXIDATION-REDUCTION; PHOSPHORUS RADIOISOTOPES; PHOSPHORYLATION; PRECIPITIN TESTS; PROTO-ONCOGENE PROTEINS C-JUN; TRANSCRIPTION FACTOR AP-1; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0031036939     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199701)18:1<26::AID-MC4>3.0.CO;2-P     Document Type: Article

References (34)

1. Hennings H, Shores R, Wenk ML, Spangler LF, Tarone R, Yuspa SH. Malignant conversion of mouse skin tumors is increased by tumor initiators and unaffected by tumor promoters. Nature 304:67-69, 1983.
2. Slaga TJ. Critical events in skin tumor promotion and progression. In: Sudilovsky O (ed), Boundaries Between Promotion and Progression During Carcinogenesis. Plenum Press, New York, 1991, pp. 19-29.
3. Domann FE, Levy JP, Finch JS, Bowden GT. Constitutive AP-1 DNA binding and transactivating ability of malignant but not benign mouse epidermal cells. Mol Carcinog 9:61-66, 1994.
4. Domann FE, Levy JP, Birrer MJ, Bowden GT. Stable expression of a c-Jun deletion mutant in two malignant mouse epidermal cell lines blocks tumor formation in nude mice. Cell Growth Differ 5:9-16, 1994.
5. Vogt PK, Bos TJ. Jun: Oncogene and transcription factor. Adv Cancer Res 55:1-34, 1990.
6. Briata P, D'Anna F, Franzi AT, Gherzi R. AP-1 activity during normal human keratinocyte differentiation: Evidence for a cytosolic modulator of AP-1/DNA binding. Exp Cell Res 204:136-146, 1993.
7. Angel P, Baumann I, Stein B, Deluis H, Rahmsdorf HJ, Herrlich P. 12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5′-flanking region. Mol Cell Biol 7:2256-2266, 1987.
8. Matrisian LM, Leroy P, Ruhlmann C, Gesnel MC, Breathnach R. Isolation of the oncogene and epidermal growth factor-induced transin gene: Complex control in rat fibroblasts. Mol Cell Biol 6:1679-1686, 1986.
9. Friezner Degen SJ, Heckel JL, Reich E, Degen JL. The murine urokinase-type plasminogen activator gene. Biochemistry 26:8270-8279, 1987.
10. Angel P, Masayoshi I, Chiu R, et al. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49:729-739, 1987.
11. Schonthal A, Herrlich P, Rahmsdorf HJ, Ponta H. Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters. Cell 54:325-334, 1988.
12. Gutman A, Wasylyk B. The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites. EMBO J 9:2241-2246, 1990.
13. Dong Z, Birrer MJ, Watts RG, et al. Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc Natl Acad Sci USA 19:609-613, 1994.
14. Ha oncogene and form benign papillomas in skin grafts on athymic nude mouse hosts. Cancer Res 48:165-169, 1988.
15. Gruda MC, Kovary K, Metz R, Bravo R. Regulation of Fra-1 and Fra-2 phosphorylation differs during the cell cycle of fibroblasts and phosphorylation in vitro by MAP kinase affects DNA binding activity. Oncogene 9:2537-2547, 1994.
16. Boyle WJ, Smeal T, Defize LH, et al. Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell 64:573-584, 1991.
17. De Groot RP, Auwerx J, Bourouis M, Sassone-Corsi P. Negative regulation of Jun/AP-1: Conserved function of glycogen synthase kinase 3 and the Drosophila kinase shaggy. Oncogene 8:841-847, 1993.
18. Nikolakaki E, Coffer PJ, Hemelsoet R, Woodgett JR, Defize LHK. Glycogen synthase kinase 3 phosphorylates Jun family members in vitro and negatively regulates their transactivating potential in intact cells. Oncogene 8:833-840, 1993.
19. Sassone-Corsi P, Sisson JC, Verma IM. Transcriptional autoregulation of the proto-oncogene fos. Nature 334:314-319, 1988.
20. Smeal T, Binetruy B, Mercola D, et al. Oncoprotein-mediated signalling cascade stimulates c-Jun activity by phosphorylation of serines 63 and 73. Mol Cell Biol 12:3507-3513, 1992.
21. Abate C, Patel L, Rauscher FJ III, Curran T. Redox regulation of Fos and Jun DNA-binding activity in vitro. Science 249:1157-1161, 1990.
22. Okuno H, Akahori A, Sato H, Xanthoudakis S, Curran T, Iba H. Escape from redox regulation enhances the transforming activity of Fos. Oncogene 8:695-701, 1993.
23. Xanthoudakis S, Curran T. Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity. EMBO J 11:653-665, 1992.
24. Auwerx J, Sassone-Corsi P. IP-1: A dominant inhibitor of Fos/ Jun whose activity is modulated by phosphorylation. Cell 64:983-993, 1991.
25. Monteclaro FS, Vogt PK. A Jun-binding protein related to a putative tumor suppressor. Proc Natl Acad Sci USA 90:6726-6730, 1993.
26. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcriptional initiation by RNA polymerase II in a soluble extract from isolated nuclei. Nucleic Acids Res 11:1475-1489, 1983.
27. Chomczynski P, Sachhi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987.
28. Ryder K, Lau LF, Nathans D. A gene activated by growth factors is related to the oncogene v-jun. Proc Natl Acad Sci USA 85:1487-1491, 1988.
29. Tso JY, Sun XH, Kao TH, et al. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: Genomic complexity and molecular evolution of the gene. Nucleic Acids Res 13:2485-2502, 1985.
30. Lord KA, Hoffman-Lieberman B, Lieberman DA. Complexity of the immediate early response of myeloid cells to terminal differentiation and growth arrest includes ICAM-1, Jun B and histone variants. Oncogene 5:387-396, 1990.
31. Datta R, Sherman ML, Stone RM, Kufe D. Expression of the jun-B gene during induction of monocytic differentiation. Cell Growth Differ 2:43-49, 1991.
32. Schlingensiepen KH, Schlingensiepen R, Kunst M, et al. Opposite functions of Jun B and c-Jun in growth regulation and neuronal differentiation. Dev Genet 14:305-312, 1993.
33. Schutte J, Viallet J, Nau M, Segal S, Fedorko J, Minna J. Jun-b inhibits and c-fos stimulates the transforming and trans-activating activities of c-jun. Cell 59:987-997, 1989.
34. Chiu R, Angel P, Karin M. Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun. Cell 59:979-986, 1989.